請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/70614
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 劉振軒(Chen-Hsuan Liu) | |
dc.contributor.author | Sinling Wang | en |
dc.contributor.author | 王馨翎 | zh_TW |
dc.date.accessioned | 2021-06-17T04:32:38Z | - |
dc.date.available | 2023-08-13 | |
dc.date.copyright | 2018-08-13 | |
dc.date.issued | 2018 | |
dc.date.submitted | 2018-08-10 | |
dc.identifier.citation | 1. Androutsopoulos, V.P., Tsatsakis, A.M., Spandidos, D.A., 2009. Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention. BioMed Central Cancer 9, 187-187.
2. Arai, K., Lee, K., Berthiaume, F., Tompkins, R.G., Yarmush, M.L., 2001. Intrahepatic amino acid and glucose metabolism in a D-galactosamine-induced rat liver failure model. Hepatology 34, 360-371. 3. Balogh, J., Victor, D., Asham, E.H., Burroughs, S.G., Boktour, M., Saharia, A., Li, X., Ghobrial, R.M., Monsour, H.P., 2016. Hepatocellular carcinoma: a review. Journal of Hepatocellular Carcinoma 3, 41-53. 4. Bosoi, C.R., Rose, C.F., 2009. Identifying the direct effects of ammonia on the brain. Metabolic Brain Disease 24, 95-102. 5. Caraguel, C.G.B., Stryhn, H., Gagné, N., Dohoo, I.R., Hammell, K.L., 2011. Selection of a Cutoff Value for Real-Time Polymerase Chain Reaction Results to Fit a Diagnostic Purpose: Analytical and Epidemiologic Approaches. Journal of Veterinary Diagnostic Investigation 23, 2-15. 6. Chang, C.H., Wang, H.E., Liaw, P.Y., Peng, C.C., Peng, R.Y., 2012. Antrodia cinnamomea exhibits a potent neuroprotective effect in the PC12 Cell-Abeta25-35 model - pharmacologically through adenosine receptors and mitochondrial pathway. Planta Medica 78, 1813-1823. 7. Chang, T.K., Chen, J., Teng, X.W., 2006. Distinct role of bilobalide and ginkgolide A in the modulation of rat CYP2B1 and CYP3A23 gene expression by Ginkgo biloba extract in cultured hepatocytes. Drug Metabolism and Disposition: The Biological Fate of Chemicals 34, 234-242. 8. Chang, T.T., Chou, W.N., 2004. Antrodia cinnamomea reconsidered and A. salmonea sp. nov. on Cunninghamia konishii in Taiwan. 9. Chen, W.L., Ho, Y.P., Chou, J.C., 2016. Phenologic variation of major triterpenoids in regular and white Antrodia cinnamomea. Botanical Studies 57, 33. 10. Chen, Y.J., Cheng, P.C., Lin, C.N., Liao, H.-F., Chen, Y.-Y., Chen, C.C., Lee, K.M., 2008. Polysaccharides from Antrodia camphorata mycelia extracts possess immunomodulatory activity and inhibits infection of Schistosoma mansoni. International Immunopharmacology 8, 458-467. 11. Chen, Y.Y., Liu, F.C., Wu, T.S., Sheu, M.J., 2015. Antrodia cinnamomea Inhibits Migration in Human Hepatocellular Carcinoma Cells: The Role of ERp57 and PGK-1. American Journal of Chinese Medicine 43, 1671-1696. 12. Chiu, H.-W., Hua, K.-F., 2016. Hepatoprotective Effect of Wheat-Based Solid-State Fermented Antrodia cinnamomea in Carbon Tetrachloride-Induced Liver Injury in Rat. PloS One 11, e0153087. 13. Doostdar, H., Helen Grant, M., Melvin, W.T., Wolf, R., Danny Burke, M., 1993. The effects of inducing agents on cytochrome P450 and UDP-glucuronyltransferase activities in human HEPG2 hepatoma cells. Biochemical Pharmacology 46, 629-635. 14. Fisher, C.D., Lickteig, A.J., Augustine, L.M., Ranger-Moore, J., Jackson, J.P., Ferguson, S.S., Cherrington, N.J., 2009. Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition 37, 2087-2094. 15. Geethangili, M., Tzeng, Y.M., 2011. Review of Pharmacological Effects of Antrodia camphorata and Its Bioactive Compounds. Evidence-Based Complementary and Alternative Medicine 2011, 212641. 16. Hseu, Y.C., Chang, W.C., Hseu, Y.T., Lee, C.Y., Yech, Y.J., Chen, P.C., Chen, J.Y., Yang, H.L., 2002. Protection of oxidative damage by aqueous extract from Antrodia camphorata mycelia in normal human erythrocytes. Life Sciences 71, 469-482. 17. Hseu, Y.C., Chen, S.C., Tsai, P.C., Chen, C.S., Lu, F.J., Chang, N.W., Yang, H.L., 2007. Inhibition of cyclooxygenase-2 and induction of apoptosis in estrogen-nonresponsive breast cancer cells by Antrodia camphorata. Food and Chemical Toxicology 45, 1107-1115. 18. Hsieh, Y.C., Rao, Y.K., Wu, C.-C., Huang, C.Y.F., Geethangili, M., Hsu, S.L., Tzeng, Y.M., 2010. Methyl Antcinate A from Antrodia camphorata Induces Apoptosis in Human Liver Cancer Cells through Oxidant-Mediated Cofilin- and Bax-Triggered Mitochondrial Pathway. Chemical Research in Toxicology 23, 1256-1267. 19. Hsu, Y.L., Kuo, Y.C., Kuo, P.L., Ng, L.T., Kuo, Y.H., Lin, C.C., 2005. Apoptotic effects of extract from Antrodia camphorata fruiting bodies in human hepatocellular carcinoma cell lines. Cancer Letters 221, 77-89. 20. Hsu, Y.L., Kuo, P.L., Cho, C.Y., Ni, W.C., Tzeng, T.F., Ng, L.T., Kuo, Y.H., Lin, C.C., 2007. Antrodia cinnamomea fruiting bodies extract suppresses the invasive potential of human liver cancer cell line PLC/PRF/5 through inhibition of nuclear factor kappaB pathway. Food and Chemical Toxicology 45, 1249-1257. 21. Huang, C.H., Chang, Y.Y., Liu, C.W., Kang, W.Y., Lin, Y.L., Chang, H.C., Chen, Y.C., 2010. Fruiting body of Niuchangchih (Antrodia camphorata) protects livers against chronic alcohol consumption damage. Journal of Agricultural and Food Chemistry 58, 3859-3866. 22. Huang, T.H., Chiu, Y.H., Chan, Y.L., Wang, H., Li, T.L., Liu, C.Y., Yang, C.T., Lee, T.Y., You, J.S., Hsu, K.H., Wu, C.J., 2015. Antrodia cinnamomea alleviates cisplatin-induced hepatotoxicity and enhances chemo-sensitivity of line-1 lung carcinoma xenografted in BALB/cByJ mice. Oncotarget 6, 25741-25754. 23. Janevska, D., Chaloska-Ivanova, V., Janevski, V., 2015. Hepatocellular Carcinoma: Risk Factors, Diagnosis and Treatment. Open Access Macedonian Journal of Medical Sciences 3, 732-736. 24. Kudo, M., 2015. Surveillance, Diagnosis, Treatment, and Outcome of Liver Cancer in Japan. Liver Cancer 4, 39-50. 25. Kuo, Y.H., Lin, C.H., Shih, C.C., 2015. Ergostatrien-3beta-ol from Antrodia camphorata inhibits diabetes and hyperlipidemia in high-fat-diet treated mice via regulation of hepatic related genes, glucose transporter 4, and AMP-activated protein kinase phosphorylation. Journal of Agricultural and Food Chemistry 63, 2479-2489. 26. Lee, I.H., Huang, R.L., Chen, C.T., Chen, H.C., Hsu, W.C., Lu, M.K., 2002. Antrodia camphorata polysaccharides exhibit anti-hepatitis B virus effects. FEMS Microbiology Letters 209, 63-67. 27. Li, H.-X., Lu, Z.-M., Geng, Y., Gong, J.-S., Zhang, X.-J., Shi, J.-S., Xu, Z.-H., Ma, Y.-H., 2015. Efficient production of bioactive metabolites from Antrodia camphorata ATCC 200183 by asexual reproduction-based repeated batch fermentation. Bioresource Technology 194, 334-343. 28. Lien, H.M., Lin, H.W., Wang, Y.J., Chen, L.C., Yang, D.Y., Lai, Y.Y., Ho, Y.S., 2009. Inhibition of Anchorage-Independent Proliferation and G0/G1 Cell-Cycle Regulation in Human Colorectal Carcinoma Cells by 4,7-Dimethoxy-5-Methyl-l,3-Benzodioxole Isolated from the Fruiting Body of Antrodia camphorate. 29. Limdi, J.K., Hyde, G.M., 2003. Evaluation of abnormal liver function tests. Postgraduate Medical Journal 79, 307-312. 30. Lin, L.T., Tai, C.J., Su, C.H., Chang, F.M., Choong, C.Y., Wang, C.K., Tai, C.J., 2015. The Ethanolic Extract of Taiwanofungus camphoratus (Antrodia camphorata) Induces Cell Cycle Arrest and Enhances Cytotoxicity of Cisplatin and Doxorubicin on Human Hepatocellular Carcinoma Cells. Biomed Research International 2015, 415269. 31. Liu, D.Z., Liang, Y.C., Lin, S.Y., Lin, Y.S., Wu, W.C., Hou, W.C., Su, C.H., 2007. Antihypertensive activities of a solid-state culture of Taiwanofungus camphoratus (Chang-chih) in spontaneously hypertensive rats. Bioscience, Biotechnology, and Biochemistry 71, 23-30. 32. Liu, Y.-M., Liu, Y.-K., Lan, K.-L., Lee, Y.-W., Tsai, T.-H., Chen, Y.-J., 2013. Medicinal Fungus Antrodia cinnamomea Inhibits Growth and Cancer Stem Cell Characteristics of Hepatocellular Carcinoma. 33. Liu, Y.W., Lu, K.H., Ho, C.T., Sheen, L.Y., 2012. Protective effects of Antrodia cinnamomea against liver injury. Journal Traditional Complement Medicine 2, 284-294. 34. Lu, M.C., Shazly, M., Wu, T.Y., Du, Y.C., Chang, T.T., Chen, C.F., Hsu, Y.M., Lai, K.H., Chiu, C.P., Chang, F.R., Wu, Y.C., 2013. Recent research and development of Antrodia cinnamomea. Pharmacology and Therapeutics 139, 124-156. 35. Lu, Z.-M., Tao, W.-Y., Xu, H.-Y., Ao, Z.-H., Zhang, X.-M., Xu, Z.-H., 2011. Further studies on the hepatoprotective effect of Antrodia camphorata in submerged culture on ethanol-induced acute liver injury in rats. Natural Product Research 25, 684-695. 36. Lu, Z.M., Tao, W.Y., Zou, X.L., Fu, H.Z., Ao, Z.H., 2007. Protective effects of mycelia of Antrodia camphorata and Armillariella tabescens in submerged culture against ethanol-induced hepatic toxicity in rats. Journal of Ethnopharmacology 110, 160-164. 37. Ma, Y., Sachdeva, K., Liu, J., Ford, M., Yang, D., Khan, I.A., Chichester, C.O., Yan, B., 2004. Desmethoxyyangonin and dihydromethysticin are two major pharmacological kavalactones with marked activity on the induction of CYP3A23. Drug Metabolism and Disposition: The Biological Fate of Chemicals 32, 1317-1324. 38. Meredith, C., Scott, M.P., Renwick, A.B., Price, R.J., Lake, B.G., 2003. Studies on the induction of rat hepatic CYP1A, CYP2B, CYP3A and CYP4A subfamily form mRNAs in vivo and in vitro using precision-cut rat liver slices. Xenobiotica 33, 511-527. 39. Nyberg, S.L., Remmel, R.P., Mann, H.J., Peshwa, M.V., Hu, W.S., Cerra, F.B., 1994. Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver. Annals of Surgery 220, 59-67. 40. Park, B.K., Pirmohamed, M., Kitteringham, N.R., 1995. The role of cytochrome P450 enzymes in hepatic and extrahepatic human drug toxicity. Pharmacology and Therapeutics 68, 385-424. 41. Peng, C.H., Yang, M.Y., Yang, Y.S., Yu, C.C., Wang, C.J., 2017. Antrodia cinnamomea Prevents Obesity, Dyslipidemia, and the Derived Fatty Liver via Regulating AMPK and SREBP Signaling. American Journal of Chinese Medicine 45, 67-83. 42. Qiu, G.-H., Xie, X., Xu, F., Shi, X., Wang, Y., Deng, L., 2015. Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B. Cytotechnology 67, 1-12. 43. Rowe, I.A., 2017. Lessons from Epidemiology: The Burden of Liver Disease. Digestive Diseases 35, 304-309. 44. Schoedel, K.A., Sellers, E.M., Tyndale, R.F., 2001. Induction of CYP2B1/2 and nicotine metabolism by ethanol in rat liver but not rat brain22Abbreviations: CYP, cytochrome P450; C8 xanthate, potassium octylxanthate; NCO, nicotine C-oxidation; NDMA, N-nitrosodimethylamine; NMA, N-nitroso-N-methylaniline; NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; and SSC, saline-sodium citrate buffer. Biochemical Pharmacology 62, 1025-1036. 45. Schreiber, G., 1978. The synthesis and secretion of plasma proteins in the liver. Pathology 10, 394. 46. Shen, Y.-C., Chou, C.-J., Wang, Y.-H., Chen, C.-F., Chou, Y.-C., Lu, M.-K., 2004a. Anti-inflammatory activity of the extracts from mycelia of Antrodia camphorata cultured with water-soluble fractions from five different Cinnamomum species. FEMS Microbiology Letters 231, 137-143. 47. Shen, Y.-C., Wang, Y.-H., Chou, Y.-C., Chen, C.-F., Lin, L.-C., Chang, T.-T., Tien, J.H., Chou, C.J., 2004b. Evaluation of the Anti-Inflammatory Activity of Zhankuic Acids Isolated from the Fruiting Bodies of Antrodia camphorata. Planta Medica 70, 310-314. 48. Shu, C.H., Lung, M.Y., 2008. Effect of culture pH on the antioxidant properties of Antrodia camphorata in submerged culture. Journal of the Chinese Institute of Chemical Engineers 39, 1-8. 49. Song, T.Y., Hsu, S.L., Yen, G.C., 2005. Induction of apoptosis in human hepatoma cells by mycelia of Antrodia camphorata in submerged culture. Journal of Ethnopharmacology 100, 158-167. 50. Song, T.Y., Yen, G.C., 2003. Protective Effects of Fermented Filtrate from Antrodia camphorata in Submerged Culture against CCl4-Induced Hepatic Toxicity in Rats. Journal of Agricultural and Food Chemistry 51, 1571-1577. 51. Sun, Z., Zhang, Z., Ji, M., Yang, H., Cromie, M., Gu, J., Wang, C., Yang, L., Yu, Y., Gao, W., Wang, S.-L., 2016. BDE47 induces rat CYP3A1 by targeting the transcriptional regulation of miR-23b. Scientific Reports 6, 31958. 52. Thapa, B.R., Walia, A., 2007. Liver function tests and their interpretation. Indian Journal of Pediatrics 74, 663-671. 53. Tsai, T.C., Tung, Y.T., Kuo, Y.H., Liao, J.W., Tsai, H.C., Chong, K.Y., Chen, H.L., Chen, C.M., 2015. Anti-inflammatory effects of Antrodia camphorata, a herbal medicine, in a mouse skin ischemia model. Journal of Ethnopharmacology 159, 113-121. 54. Vanoye-Carlo, A., Gutiérrez-Ospina, G., Marcial-Quino, J., Gómez-Manzo, S., Garcia-Torres, I., De la Mora-De la Mora, I., Enríquez-Flores, S., Méndez, S.T., Phillips-Farfán, B.V., Gutiérrez-Castrellón, P., 2015. Analysis of Cyp2b1 gene expression in the rat liver and brain by multiplex PCR. Molecular & Cellular Toxicology 11, 407-414. 55. Wang, G.J., Tseng, H.W., Chou, C.J., Tsai, T.H., Chen, C.T., Lu, M.K., 2003. The vasorelaxation of Antrodia camphorata mycelia: Involvement of endothelial Ca2+-NO-cGMP pathway. Life Sciences 73, 2769-2783. 56. White, L.N.H., Davies, A., Smith, L.L., Dawson, S., de Matteis, F., 1993. Induction of CYP2B1 and 3A1, and associated monooxygenase activities by tamoxifen and certain analogues in the livers of female rats and mice. Biochemical Pharmacology 45, 21-30. 57. Wright, A.T., Cravatt, B.F., 2007. Chemical proteomic probes for profiling cytochrome P450 activities and drug interactions in vivo. Chemistry and Biology 14, 1043-1051. 58. Yang, H.L., Chen, C.S., Chang, W.H., Lu, F.J., Lai, Y.C., Chen, C.C., Hseu, T.H., Kuo, C.T., Hseu, Y.C., 2006. Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata. Cancer Letters 231, 215-227. 59. Yang, H.L., Kuo, Y.H., Tsai, C.T., Huang, Y.T., Chen, S.C., Chang, H.W., Lin, E., Lin, W.H., Hseu, Y.C., 2011. Anti-metastatic activities of Antrodia camphorata against human breast cancer cells mediated through suppression of the MAPK signaling pathway. Food and Chemical Toxicology 49, 290-298. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/70614 | - |
dc.description.abstract | 牛樟芝為台灣民俗的珍貴藥用真菌,經常被用於治療肝臟疾病、高血壓、腹痛、腹瀉或其它疾病;近年來有關牛樟芝的研究大多著重於多種人類癌症的治療以及保護肝臟免於酒精及病原感染等所造成的損傷。肝炎病毒感染目前被認為是造成肝癌的最主要成因,其次為酗酒,由於難以早期診斷,且不易進行手術,以及缺乏有效治療藥物,導致肝癌患者的死亡率及復發率都很高。為開發具有保護肝臟及治療功能的藥物,以補足傳統治療的不足,本研究將評估牛樟芝皿培子實體的酒精初萃物保護肝臟細胞以及抑制肝癌細胞的效果。我們的研究結果顯示,本初萃物能夠有效抑制HepG2及HA59T兩個肝癌細胞的增生及降低其存活率,並且使肝癌細胞的細胞週期停滯於G2/M期,同時也抑制肝癌細胞遷移及侵潤等腫瘤細胞的癌化特性。此外,我們給與初代培養的大鼠肝細胞及肝細胞株(Clone 9) D-氨基半乳糖(D-galactosamine)來模擬肝細胞功能的損傷,結果發現給與D-氨基半乳糖降低了肝細胞製造白蛋白(在基因及蛋白質層級)、合成尿素及表現解毒酵素細胞色素的能力,而投與本初萃物能有效逆轉因D-氨基半乳糖所造成的肝細胞功能損傷。總結本研究的成果發現,本研究所使用之皿培牛樟芝子實體酒精初萃物能有效抑制肝癌細胞的癌化特性,同時保護肝細胞免於因D-氨基半乳糖所造成的肝功能損傷。 | zh_TW |
dc.description.abstract | Antrodia cinnamomea (AC) is a treasured endemic Taiwanese medicinal mushroom and is used to treat liver diseases, hypertension, abdominal pain, diarrhea, and other diseases. Recent studies related to AC focused on the treatment of various cancers and protection against liver injuries causing by alcohol and pathogen infection etc. Hepatocellular carcinoma (HCC) accounts for 70–85% of the total liver cancer burden and usually develops within a background of advanced chronic liver disease, mainly related to infection of hepatitis virus and alcohol abuse. Mortality and recurrence rate of liver cancer remains high because of the difficulty of early diagnosis, hard operation and lack of useful therapeutic drugs. To develop alternative or adjuvant treatments for improving the clinical outcome of the conventional therapy, ethanol extract of dish-cultured AC fruiting body was used to evaluate its antitumor and hepatoprotective effects. The result showed that AC treatment inhibited proliferation and reduced viability of both human HCC cells, HepG2 and HA59T, and arrested the cancer cells in the G2/M phase of cell cycle. At the same time, AC treatment also inhibited their migration and invasion which is the malignant characteristics of cancer cell. Furthermore, application of D-galactosamine (D-gal) damaged the functions of rat liver cells, Clone 9, and rat primary liver culture cells on albumin production (in mRNA and protein levels), urea synthesis and cytochrome P450 expression. The addition of the AC protected liver cells from those injuries caused by D-gal. In conclusion, the ethanol extract of dish-cultured AC fruiting body inhibited malignant characteristics of HCC cells while protected liver from injury caused by D-gal. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T04:32:38Z (GMT). No. of bitstreams: 1 ntu-107-R05644006-1.pdf: 2961226 bytes, checksum: e1529d871ead6feb85a5b0af64b843e3 (MD5) Previous issue date: 2018 | en |
dc.description.tableofcontents | 中文摘要 i
Abstract ii Abbreviations vii Chapter 1. Background and Literature Review 1 1.1 Introduction of Antrodia cinnamomea 1 1.1.1 Antrodia cinnamomea 1 1.1.2 Fruiting body and mycelium 1 1.1.3 AC and its host tree 2 1.1.4 AC artificial culture methods 2 1.1.5 Chemical constituents 4 1.1.6 Pharmacological effect of AC extracts research 5 1.1.7 Treatment of AC in various types of cancers 7 1.2 Assays for liver function 8 1.3 Liver disease epidemics in Taiwan 12 1.4 Clinical treatment of liver cancer 13 1.5 Literature review of AC on Liver disease 14 1.5.1 AC treatment in liver injuries 14 1.5.2 AC treatment in liver cancer 17 Chapter 2. Introduction 20 Chapter 3. Materials and methods 24 3.1 Chemicals 24 3.2 AC preparation 24 3.3 Cell culture 24 3.4 Cell viability assay 25 3.5 Cell cycle analysis 26 3.6 Colony formation assay 26 3.7 Cell migration assay 27 3.7.1 Wound healing assay 27 3.7.2 Transwell migration 27 3.8 Cell invasion assay 28 3.9 ELISA assay 28 3.10 Urea detection assay 30 3.11 RNA extraction 30 3.12 Reverse transcription 31 3.13 Real-time quantitative PCR 31 3.14 Statistical analysis 31 Chapter 4. Results 33 4.1 Antitumor efficacy of AC on HCC cells 33 4.1.1 The effects of AC on viability of HCC cells and non-cancer cells 33 4.1.2 The effects of AC on cell cycle of HCC cells 33 4.1.3 The effects of AC on colony formation of HCC cells 34 4.1.4 The effects of AC on migration of HCC cells 34 4.1.5 The effects of AC on invasion of HCC cells. 35 4.2 Hepatoprotective effects of AC against liver injuries induced by D-gal 35 4.2.1 The effects of D-gal on normal hepatocytes 35 4.2.2 The effects of AC on albumin and CYP450 expression in mRNA level 35 4.2.3 The effects of AC on albumin and CYP450 in protein level 37 4.2.4 The effects of AC on urea synthesis 38 Chapter 5. Discussion 39 Tables 45 Figures 46 Figure 1. AC treatment inhibited viability of human HCC cells 46 Figure 2. AC treatment arrested cell cycle of human HCC cells in G2/M phase but rat non-cancer hepatocytes 48 Figure 3. AC treatment did not cause rat hepatocytes death 49 Figure 4. AC treatment inhibited wound healig migration of human HCC cells 50 Figure 5. AC treatment inhibited transwell migration of human HCC cells 52 Figure 6. AC treatment inhibited invasion of human HCC cells 54 Figure 7. AC treatment inhibited colony formation of human HCC cells 55 Figure 8. D-gal induced rat hepatocytes death 56 Figure 9. AC treatment increased albumin expression in mRNA levels of rat hepatocytes against liver injury induced by D-gal 57 Figure 10. AC treatment increased CYP1A1, CYP2B1, and CYP3A23 expression in mRNA levels of rat hepatic cell line against liver injury induced by D-gal 58 Figure 11. AC treatment decreased CYP1A1, CYP2B1, and CYP3A23 expression in mRNA levels of rat primary liver cells against liver injury induced by D-gal 59 Figure 12. AC treatment increased albumin expression in protein level on rat primary liver cells against liver injury induced by D-gal 60 Figure 13. AC treatment increased CYP450 expression in protein level on rat primary liver cells against liver injury induced by D-gal 61 Figure 14. AC treatment affected urea synthesis on rat hepatocytes against liver injury induced by D-gal 62 Acknowledgements 63 References 64 | |
dc.language.iso | en | |
dc.title | 評估皿培牛樟芝子實體抑制肝癌細胞及以D-氨基半乳糖誘發肝細胞損傷保護之效果 | zh_TW |
dc.title | To Evaluate Dish-Cultured Antrodia Cinnamomea Fruiting
Body on Anti-Liver Cancer Effects and Its Protection from Liver Injuries Induced by D-galactosamine | en |
dc.type | Thesis | |
dc.date.schoolyear | 106-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 廖泰慶(Albert Taiching Liao),陳林祈(Linchi Chen),林辰栖(Chen-Si Lin) | |
dc.subject.keyword | 牛樟芝,皿培子實體,人類肝細胞癌,大鼠肝細胞,D-氨基半乳糖, | zh_TW |
dc.subject.keyword | Antrodia cinnamomea,Dish-cultured fruiting body,Human hepatocellular carcinoma,Rat liver cells,D-galactosamine, | en |
dc.relation.page | 69 | |
dc.identifier.doi | 10.6342/NTU201802339 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2018-08-10 | |
dc.contributor.author-college | 獸醫專業學院 | zh_TW |
dc.contributor.author-dept | 分子暨比較病理生物學研究所 | zh_TW |
顯示於系所單位: | 分子暨比較病理生物學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-107-1.pdf 目前未授權公開取用 | 2.89 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。